In 1997 was created Salem Partners, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Los Angeles.
Among the various public portfolio startups of the fund, we may underline ZS Pharma, Onconano Medicine, Femasys We can highlight the next thriving fund investment areas, such as Ethereum, Women's. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The top activity for fund was in 2019. The higher amount of exits for fund were in 2014. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Salem Partners works on 19 percentage points less the average amount of lead investments comparing to the other organizations.
The current fund was established by John Dyett. Besides them, we counted 3 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Salem Partners, startups are often financed by Partisan Management Group, Versant Ventures, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are RiverVest, Devon Park BioVentures, Alta Partners. In the next rounds fund is usually obtained by Sofinnova Investments, RiverVest, RA Capital Management.
Funds with similar focus
Fund Name | Location |
8i Ventures | India, Maharashtra, Mumbai |
AutoBinck | The Hague, The Netherlands, Zuid-Holland |
Cycle Venture Partners | - |
ECONA AG | Berlin, Berlin, Germany |
ERGO Group | Düsseldorf, Germany, Nordrhein-Westfalen |
Evolution | California, Saratoga, United States |
Huizenga Capital Management | Illinois, Oak Brook, United States |
MDC Ventures | New York, New York, United States |
Novastar Ventures | Kenya, Nairobi, Nairobi Area |
Prudence Venture Investment Corporation | - |
Quintel Technology | New York, Rochester, United States |
Rabo Frontier Ventures | Netherlands, Utrecht, Utrecht |
RS Investments | California, San Francisco, United States |
Standish Management | California, San Francisco, United States |
Steelpoint Capital Partners | California, Solana Beach, United States |
Treeline, Inc. | Massachusetts, United States, Wakefield |
Tunisian American Enterprise Fund | District of Columbia, United States, Washington |
Zhiyou Fangcun | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Fabric | 01 Dec 2022 | Los Angeles, California, United States | |||
Fabric | 01 Jun 2021 | Los Angeles, California, United States | |||
Onconano Medicine | $23M | 09 Jul 2019 | Dallas, Texas, United States | ||
Lucid Sight | $6M | 02 Apr 2019 | Los Angeles, California, United States | ||
Rightsline | 01 Jan 2019 | Los Angeles, California, United States | |||
Onconano Medicine | $11M | 17 May 2018 | Dallas, Texas, United States | ||
Lucid Sight | $3M | 16 May 2016 | Los Angeles, California, United States | ||
Femasys | $10M | 29 Apr 2015 | Georgia, United States | ||
ZS Pharma | $46M | 23 Oct 2012 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Fabric | 01 Dec 2022 | Los Angeles, California, United States | |||
Fabric | 01 Jun 2021 | Los Angeles, California, United States | |||
Onconano Medicine | $23M | 09 Jul 2019 | Dallas, Texas, United States | ||
Lucid Sight | $6M | 02 Apr 2019 | Los Angeles, California, United States | ||
Rightsline | 01 Jan 2019 | Los Angeles, California, United States | |||
Onconano Medicine | $11M | 17 May 2018 | Dallas, Texas, United States | ||
Lucid Sight | $3M | 16 May 2016 | Los Angeles, California, United States | ||
Femasys | $10M | 29 Apr 2015 | Georgia, United States | ||
ZS Pharma | $46M | 23 Oct 2012 | - |